Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

CGTN: China calls for more inclusive development in post-COVID world

BEIJING, Nov. 23, 2020 /PRNewswire/ -- With COVID-19 still causing widespread damage across the world,China on Saturday called for concerted efforts from major economies to promote more inclusive development and improve global governance in the post-pandemic era. &amp;nbsp; Read the ori...

2020-11-23 09:09 2169

Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies

DAEJEON, South Korea and CASTRES, France, Nov. 23, 2020 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have announced their plans to form a strategic partnership in the field of immuno-oncology research. The decision has been acknowle...

2020-11-23 09:00 2038

Infinitus Harnesses eCommerce to Offer Greater Direct Selling Opportunities for Partners

GUANGZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Ahead of key eCommerce festivals such as 11.11 and Black Friday, Infinitus (China) Company Ltd ("Infinitus"), a purveyor of health products and solutions, has harnessed the power of social e-Commerce to open up new direct selling opportunities for ...

2020-11-23 09:00 1842

G20 Riyadh Summit: Release of Leaders' Declaration

RIYADH, Saudi Arabia, Nov. 23, 2020 /PRNewswire/ -- G20 Leaders endorsed their declaration at the end of their summit todayNovember 22, 2020, including agreements on steps to be taken to protect lives and shape a better future. "We, the G20 Leaders, meeting for the second time under the Saudi Pr...

2020-11-23 08:30 1357

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020

SAN FRANCISCO and SUZHOU, China, Nov. 23, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2020-11-23 08:00 5463

Firestorm Fire Protection PTY Announces Rebranding, Changes Name to United Safety

A leader in the fire protection space has unveiled a new name, logo, and look. EXTON, Pa., Nov. 22, 2020 /PRNewswire/ -- Kristian Bischoff, CEO and Managing Director announced as ofNovember 1st, 2020 that a company-wide rebranding had been completed. "When Firestorm was purchased by United Safe...

2020-11-23 07:00 1492

Novel Antioxidant Seen as an Effective Strategy for Peripheral Artery Disease

OMAHA, Ne., Nov.20, 2020 /PRNewswire/ -- Researchers within the School of Health and Kinesiology at theUniversity of Nebraska at Omaha (UNO) have found that a novel antioxidant can provide a number of health benefits for individuals with peripheral artery disease. The antioxidant specifically ta...

2020-11-20 23:07 2217

Antengene Corporation, an Innovative Cancer Biotech Company, is Listed on the Main Board of the Hong Kong Stock Exchange

HONG KONG, Nov. 20, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer medicines, today announced that the company was officially listed and it's shares commenced trading on the Main Board...

2020-11-20 21:09 12786

RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease

RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy The Phase 3 study is expected to recruit up to 125 patients across approximately 40 U.S. clinical sites RHB-...

2020-11-20 21:00 5232

INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting

Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients PLYMOUTH MEETING, Pa., Nov. 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely de...

2020-11-20 21:00 5401

Ortho's CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals

- Ortho's VITROS® SARS-CoV-2 antigen test can detect SARS-CoV-2 infection in asymptomatic individuals. - The low-cost VITROS antigen test can run up to 130 tests per hour and is a viable choice for frequent, high-throughput testing and monitoring of large community populations. RARITAN, N.J., N...

2020-11-20 20:00 1463

CARsgen Therapeutics to Present Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition in December

SHANGHAI, Nov. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, today announced that data from its global multiple myeloma program will be presented, including two oral presentations and one poster session, at the 62nd American Society of Hematology (ASH)...

2020-11-20 19:00 3267

Successful Day 1 of COMEUP 2020, with more than 50,000 accumulative online views, 7,500 pre-registrations, and 400,000 accumulative visits to the homepage

* COMEUP 2020: Day 1 (19 November) * Successful Day 1, with academic conferences in 'Digital healthcare' to 'Environment' * Day 1 afternoon sessions featured lectures and passionate discussions in 2 areas, 'Digital healthcare' and 'Environment' * World-famous experts in healthcare and clea...

2020-11-20 18:10 1509

Successful Day 1 of COMEUP 2020, with more than 50,000 accumulative online views, 7,500 pre-registrations, and 400,000 accumulative visits to the homepage

Concord Medical Schedules 2020 Annual Meeting of Shareholders

BEIJING, Nov. 20, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...

2020-11-20 17:00 4470

WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou

HANGZHOU, China, Nov. 20, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced its biologics integrated innovation center has been in operation inHangzhou, Zhejiang province, China. From process deve...

2020-11-20 16:30 1883

Asian Power Devices: Powering modern technology in an ever-shifting landscape

TAIPEI, Nov. 20, 2020 /PRNewswire/ -- Medical field is a critical market for power supplies-- APD introduces customized power supply solutions for medical equipment and network equipment. Its systems meet all EMI, temper...

2020-11-20 15:46 1246

Asian Power Devices: Powering modern technology in an ever-shifting landscape

Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine

SINGAPORE, Nov. 20, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare services provider inAsia, announced that it will significantly expand its cold storage warehouse capacity in key regional markets over the next 12 months. As the largest vaccines and cold chain pharmaceutical distributo...

2020-11-20 15:31 5528

Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine

Indonesian Government Presents Education on COVID-19 Vaccines

JAKARTA, Indonesia, Nov. 20, 2020 /PRNewswire/ -- The government, through the COVID-19 Handling and Economic Recovery (KPCPEN) continues to battle the COVID-19 pandemic inIndonesia by accelerating the preparation of the Sinovac vaccine, which is currently entering stage III clinical trials and h...

2020-11-20 15:28 1538

Indonesian Government Presents Education on COVID-19 Vaccines

Huize Announces 2020 Third Quarter Results

GWP and Total Operating Revenue Achieved Double-Digit YOY Growth Hitting Record Quarterly Highs Results Highlights: * GWP facilitated on our platform increased by 41.2% to a record quarterly high of RMB779.0 million, compared to RMB551.8 million in the third quarter of 2019. * Total operat...

2020-11-20 15:10 10642

Qiming's Portfolio Company Antengene Lists on Main Board of HKEX

SHANGHAI, Nov. 20, 2020 /PRNewswire/ -- Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The issue price isHK$18.08 per share; the stock opens at HK$ 19.6 per share, up 8.41%, with a market cap of HK$ 13.097 bi...

2020-11-20 14:22 5974

1 ... 593 594 595596597 598 599 ... 807